-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB BIOTHERAPEUTICS - PHASE 2B SAFEGUARD STUDY ENROLLMENT TO COMPLETE IN Q4 2026; TOPLINE DATA IN 2H 2027

Reuters·10/13/2026 12:30:01

Please log in to view news